Igor Kuchma

As expected, following Pfizer’s announcement, Moderna published phase 3 results presumably showing nearly 95% protection. Nevertheless, we shouldn’t expect a massive distribution until the middle of next year. Besides that, the number of conspiracy theorists is growing; meanwhile, confidence in a vaccine remains low. According to a study conducted by EL PAÍS, just 24% of […]

This year, no one will go without a present – our Black Friday sale is fast approaching with discounts of up to 60%. From November 23 to December 1, you’ll have the opportunity to purchase a subscription at our lowest possible price, and – on top of that – this year you’ll also have an […]

Last week we found out that Pfizer and Germany’s BioNTech vaccine is +90% effective, giving markets and the economy something to feel good about. The next in the line is Moderna, which is expected to publishing the first results of the crucial late-stage clinical trial for mRNA-1273 this week. In the last press release, Moderna […]

As forecasted by many, Biden won the elections, but we could be still away from the official announcement as the Trump campaign filed a series of lawsuits, many of which will be brought Monday. Thus, we can’t discount that final results will be postponed for a longer period. On the other hand, it is important […]

The worsening epidemiological situation and the lack of a new stimulus package suggest that the observed recovery in the third quarter is most likely of a short-term nature, thus by the end of the year consumer activity may significantly slow down. In this context, it shouldn’t be a surprise that risk assets, including tech giants, […]

The WHO says we are at a critical juncture in the COVID-19 pandemic, particularly in the northern hemisphere. The next few months are going to be very tough and some countries are on a dangerous track, thus leaders will eventually have to act in order to turn the outbreak around. Investors meanwhile are waiting to […]

Covid cases continue growing all over the world, Italy issues first negative-yield three-year bond, democrats, and republicans still cannot agree on new fiscal relief for American workers and businesses, better than expected macro-economic data relieved some fears about a slow economic recovery, and third-quarter corporate earnings reporting season kicked off. Coronavirus is back on track...

The cats and mouse game between Republicans and Democrats continues. The Trump administration agreed on a stimulus proposal of $1.8 trillion, but House Speaker Nancy Pelosi called it “insufficient”, rejecting it. Thus, hopes over a new relief package before the elections have been shuttered. A similar situation can be observed either with Brexit talks. The […]

We enter the fourth and the last quarter of the year, however same problems persist – pandemic is not gone and more countries register a rise in cases; the future of the U.S. elections is unclear with Trump taken to Walter Reed medical center and will be hospitalized ‘for the next few days’. Stakes on Joe Biden’s victory […]

Fears of a second wave of COVID-19 haven been overshadowed by the possibility of a broader armed conflict between Armenia and Azerbaijan over the breakaway Nagorno-Karabakh region. Multiple countries have already called on Yerevan and Baku to end hostilities and immediately restart dialog, but the escalation continues. Turkey already said they support Azerbaijan, meanwhile, Russia […]